A

Alta Life Sciences

5 employees

Alta Life Sciences is a leading multistage venture capital investment firm in Spain.

Investor insights

Sectors invested in

Biotechnology10
Health Care8
Wellness3
Medical Device3
VHIO3
Life Science3
NSCLC3
Myc3
Oncology3
Breast cancer3
Glioblastoma3
antimicrobial resistance2
diagnostics2
sepsis2
Machine Learning2
Medical2
Artificial Intelligence2
Software2
AI2
Medical Devices2

Funding rounds participated in

$1.5M sweet spot round size

Most of their 14 investments are in rounds between $3.3M and $20M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Biotechnology
Financial Services

Date founded

2016

Investments made

d

deepull raised $13M on October 20, 2022

Investors: CDTI, Centre for the Development of Industrial Technology, UI Investissement and Alta Life Sciences

P

Peptomyc raised $3.3M on January 18, 2022

Investors: Healthequity, SCR and Alta Life Sciences

T

TECKEL MEDICAL (Mediktor) raised $13M on October 4, 2021

Investors: MTIP AG and Alta Life Sciences

b

binx health raised $104M on May 27, 2021

Investors: EQT Life Sciences, Parian Global Management LP, OrbiMed Advisors and Alta Life Sciences

I

INBRAIN Neuroelectronics raised $20M on March 26, 2021

Investors: CDTI, Centre for the Development of Industrial Technology, Institut Català de Finances (ICF), Asabys Partners, Vsquared Ventures, TruVenturo GmbH and Alta Life Sciences

I

Inbiomotion SL raised undisclosed on January 21, 2021

Investors: Institut Català de Finances (ICF) and Alta Life Sciences

P

Peptomyc raised $14M on December 15, 2020

Investors: AurorA Science, Healthequity, SCR, CDTI, Centre for the Development of Industrial Technology and Alta Life Sciences

d

deepull raised $4M on July 7, 2020

Investors: Alta Life Sciences

O

ONA Therapeutics raised $34M on June 16, 2020

Investors: Ysios Capital, FundPlus, Asabys Partners and Alta Life Sciences

I

INBRAIN Neuroelectronics raised $1.2M on June 11, 2020

Investors: Institut Català de Finances (ICF), Asabys Partners and Alta Life Sciences

FAQ